A new HIV prevention method, Lenacapavir, administered as a twice-yearly injection, has demonstrated superior results ...

Tengrinews.kz - A revolutionary HIV drug has been created: clinical trials have shown that its twice-yearly injections are 96 ...

An Emory-led review highlights racial disparities in sudden cardiac arrest and death among athletes, stressing the importance ...

Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.

A new study reveals that Black athletes are five times as likely as white athletes to experience sudden cardiac arrest.

Focus Universal Inc. (NASDAQ:FCUV) (”Focus” or the “Company”), a provider of patented hardware and software design technologies for Internet of Things (IoT), 5G and SEC Financial Reporting AI-Driven ...

In its annual National Influenza Vaccination Week messaging the CDC said there's still time to benefit from getting a flu ...

Medical school residents and fellows learn skill including how to relax with singing bowls and make a jingle dress.

Teaching in the English Department for nearly two decades, Ziff is remembered for his generous mentorship and influential ...

Of 33 people interviewed by health officials, 27 (82%) reported eating cucumbers in the days prior to illness.

Even if your long winter's naps don't include visions of sugarplums, sleep is essential for health. St-Onge, who also is ...

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...